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The protease-activated receptor (PAR)-2 is highly ex-
pressed in endothelial cells and vascular smooth muscle 
cells. It plays a crucial role in regulating blood pressure via 
the modulation of peripheral vascular tone. Although sev-
eral mechanisms have been suggested to explain PAR-2-
induced hypotension, the precise mechanism remains to be 
elucidated. To investigate this possibility, we investigated 
the effects of PAR-2 activation on N-type Ca2+ currents (ICa-N) 
in isolated neurons of the celiac ganglion (CG), which is 
involved in the sympathetic regulation of mesenteric artery 
vascular tone. PAR-2 agonists irreversibly diminished volt-
age-gated Ca2+ currents (ICa), measured using the patch-
clamp method, in rat CG neurons, whereas thrombin had 
little effect on ICa. This PAR-2-induced inhibition was almost 
completely prevented by -CgTx, a potent N-type Ca2+ 
channel blocker, suggesting the involvement of N-type Ca2+ 
channels in PAR-2-induced inhibition. In addition, PAR-2 
agonists inhibited ICa–N in a voltage-independent manner in 
rat CG neurons. Moreover, PAR-2 agonists reduced action 
potential (AP) firing frequency as measured using the cur-
rent-clamp method in rat CG neurons. This inhibition of AP 
firing induced by PAR-2 agonists was almost completely 
prevented by -CgTx, indicating that PAR-2 activation may 
regulate the membrane excitability of peripheral sympathet-
ic neurons through modulation of N-type Ca2+ channels. In 
conclusion, the present findings demonstrate that the acti-
vation of PAR-2 suppresses peripheral sympathetic outflow 
by modulating N-type Ca2+ channel activity, which appears 
to be involved in PAR-2-induced hypotension, in peripheral 
sympathetic nerve terminals. 1 
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INTRODUCTION 
 
Protease-activated receptors (PARs) are a group of G-protein 
coupled receptors (GPCRs) with seven transmembrane do-
mains. To date, four members of the PAR family (PAR 1-4) have 
been identified (Kawabata et al., 1999). The activation of PARs 
by proteases involves cleavage of the amino terminal sequence 
of the PAR extracellular N-terminal domain at specific sites. The 
new N-terminus exposed by cleavage acts as a ‘tethered ligand’ 
and binds to a site located in the second extracellular loop, trig-
gering G-protein coupling and intracellular signaling.  
Recently, it has been reported that PAR-2 is highly expressed 
in endothelial cells and vascular smooth muscle, suggesting a 
crucial role in regulating vascular tone (al-Ani et al., 1995; 
Hollenberg et al., 1996; Magazine et al., 1996; Saifeddine et al., 
1996). In fact, PAR-2 activation by receptor-activating peptides 
decreases blood pressure in anesthetized rats or mice in vivo 
(Cheung et al., 1998; Cicala et al., 1999; 2001; Damiano et al., 
1999; Emilsson et al., 1997; Kawabata et al., 2003). This hypo-
tension is only partially inhibited by the nitric oxide synthase 
inhibitor, L-NAME, suggesting that a nitric oxide (NO)-
independent mechanism as well as a NO-dependent mecha-
nism are involved in hypotension induced by PAR-2 activation 
(Cicala et al., 2001; Emilsson et al., 1997). However, the effect of 
PAR-2 on peripheral sympathetic activity, which regulates pe-
ripheral vascular resistance, is not fully understood. According to 
previous reports, hypotension induced by PAR-2 activation is 
maintained for around 2-3 min, and the ganglion-blocking agent 
chlorisondamine significantly increases the duration of hypoten-
sion induced by PAR-2 activation, suggesting that PAR-2-
induced hypotension may be maintained by modulating periph-
eral sympathetic tone (Cheung et al., 1998; Cicala et al., 2001; 
Emilsson et al., 1999). However, a detailed mechanism for PAR-
2 induced suppression of peripheral sympathetic outflow has not 
yet been elucidated.  
It is well documented that voltage-gated N-type Ca2+ channels 
play an important role in regulating peripheral sympathetic tone 
in postganglionic sympathetic neurons (Molderings et al., 2000; 
Shimosawa et al., 2004). In fact, decreases in blood pressure 
activate a peripheral sympathetic reflex. This enhanced periph-
eral sympathetic output increases Ca2+ influx through N-type 
Ca2+ channels located in peripheral sympathetic nerve terminals, 
which in turn triggers the release of noradrenaline (NA) from 
these terminals. Thus, any substance that modulates N-type 
Ca2+ channel activity can affect NA release from peripheral sym-
pathetic nerve terminals and significantly alter sympathetic tone 
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(Hille, 1994). It is therefore possible that PAR-2-mediated hypo-
tension is associated, in part, with the inhibition of peripheral 
sympathetic output by modulating N-type Ca2+ channels that are 
located on sympathetic nerve terminals.  
To investigate this hypothesis, we directly examined the effect 
of PAR-2 activation on N-type Ca2+ currents in isolated neurons 
of the celiac ganglion (CG), which regulates vascular sympathet-
ic tone of the mesenteric artery. Our results demonstrate that 
PAR-2 may induce hypotension by suppressing peripheral vas-
cular sympathetic activity via the inhibition of N-type Ca2+ chan-
nels located in peripheral sympathetic nerve terminals in rat CG 
neurons. Our findings provide new and significant evidence that 
proves a direct relationship between PAR-2 activation and pe-
ripheral sympathetic activity. 
 
MATERIALS AND METHODS 
 
Animals used 
Male Sprague-Dawley rats were used in all of the experiments 
conducted. They were purchased from Orient Co., Seoul, Re-
public of Korea. All procedures were performed in accordance 
with protocols approved by the Institutional Animal Care and Use 
Committee of the Yonsei University Health System (approval 
reference number: 2014-0052).  
 
Preparation of celiac ganglion neurons 
Celiac ganglion (CG) neurons were enzymatically dissociated 
using modifications of methods described previously (Chung et 
al., 2010; Schofield and Ikeda, 1988). Briefly, adult (200-300 g) 
male rats were deeply anesthetized with isoflurane (3%, 2-3 min) 
and blood was removed from blood vessels by perfusing the rats 
transcardially with cold Dulbecco’s phosphate buffer saline (D-
PBS), in the same manner as described in the preparation of 
mesenteric artery strips. Ganglia were dissected out from the 
lateral side of mesenteric artery bifurcation and placed in cold D-
PBS. The CG is surrounded by several small ganglia, which 
were removed, and it was dissected into small pieces (Sosa et 
al., 2000), and incubated in Earle’s balanced salt solution 
(EBSS), containing 0.6 mg/ml papain (Sigma-Aldrich Co., Korea) 
and 0.3 mg/ml trypsin type 1A (Sigma-Aldrich Co., Korea), at 
35°C for 45 min in a shaking water bath. After incubation, gan-
glia were dispersed into single neurons by vigorous shaking of 
the culture flask containing the ganglia. After centrifugation at 
1000 rpm, the neurons were resuspended in Dulbecco’s modi-
fied eagle medium (DMEM), containing 10% fetal bovine serum 
(FBS) and 1% penicillin/streptomycin (all from Invitrogen, USA). 
The neurons were plated onto poly-L-lysine-coated 12-mm glass 
cover slips and incubated in a humidified incubator with 95% air 
and 5% CO2. Neurons were used within 12 h after plating.  
 
Electrophysiology 
Voltage-gated Ca2+ currents (ICa) were recorded using conven-
tional whole-cell techniques. Electrode resistances varied from 
3-5 M when filled with internal solution. Measurements were 
performed using an Axopatch 200A patch-clamp amplifier (Mo-
lecular Devices, USA). Voltage and current commands and the 
digitization of membrane voltages and currents were controlled 
using a Digidata 1322A interfaced with Clampex 10.2 (pClamp 
Software, Molecular Devices, USA) on an IBM-compatible com-
puter. Data were analyzed using Clampfit (Molecular Devices, 
USA) and Prism 5.0 (GraphPad, USA). The cells were moved 
from the incubator to a recording chamber, visualized using an 
inverted microscope, and subjected to whole-cell voltage clamp 
recordings. Currents were low-pass filtered at 2 kHz using the 
four-pole Bessel filter of the amplifier. Capacitance (Cm) values 
were automatically calculated during recordings by the pClamp 
software. Action potentials were recorded in current clamp mode. 
Membrane potential measurements were low-pass filtered at 10 
kHz. Only cells with a resting membrane potential < -50 mV 
were included in the analysis. Multiple independently controlled 
syringes served as reservoirs for a gravity-driven fast drug per-
fusion system. Switching between solutions was accomplished 
by manually controlled valves. All experiments were conducted 
at room temperature.  
 
Western blot analysis 
CG, liver, and lungs from rats were rapidly removed, immediately 
frozen in liquid nitrogen, and stored at -80°C until used. The 
homogenates were prepared from these samples. Samples 
were lysed in buffer, which contained Complete Miniprotease 
inhibitors. The protein concentration was determined using a 
Bradford protein assay kit (Bio-Rad, USA). An aliquot containing 
100 g of protein from the total lysate was electrophoresed on a 
10% SDS-PAGE gel and then transferred to Immobilon-P (Milli-
pore, USA). After blocking with 5% nonfat dry milk in Tris-
buffered saline (TBS), the membrane was incubated with a PAR-
2 antibody (Santa Cruz Biotechnology Inc., USA) at an appropri-
ate dilution overnight, at 4°C, and then washed four times in 
TBS-Tween (TBS-T). The membrane was then incubated with a 
goat anti-mouse Ig (Thermo Scientific, USA) at a dilution of 
1:5000 at room temperature for 1 h, and then again washed four 
times in TBS-T. The blots were visualized using ECL reagents 
(Thermo Scientific, USA). 
 
Solutions and drugs 
The internal (pipette) solution contained the following (in mM): 
140 CsCl2, 1.2 MgCl2, 4 MgATP, 0.4 Na2GTP, 10 phosphocrea-
tine, 10 HEPES, and 10 EGTA; the solution was adjusted to pH 
7.2 with CsOH. The external (bath) solution contained (in mM) 
155 tetraethylammonium (TEA)-Cl, 2.5 CaCl2, 1.2 MgCl2, 14 
glucose, and 10.5 HEPES; the solution was adjusted to pH 7.4 
with TEA-OH. The external solution for current clamp recordings 
contained the following (in mM): 143 NaCl, 5.4 KCl, 2.5 CaCl2, 
1.2 MgCl, 10 glucose, and 10 HEPES; the solution was adjusted 
to pH 7.4 with NaOH. The pipette solution used for current clamp 
recordings contained the following (in mM): 113 K-gluconate, 30 
KCl, 1.2 MgCl2, 4 MgATP, 0.4 Na2GTP, 10 phosphocreatine, 10 
HEPES, and 0.05 EGTA; the solution was adjusted to pH 7.2 
with KOH. Sample lysis buffer consisted of 20 mM Tris–HCl, pH 
7.4, 1 mM EDTA, 150 mM NaCl, 0.1% (w/v) SDS. -conotoxin 
GVIA (CgTx) was purchased from Alomone (Alomone Laborato-
ries, Israel). SLIGRL-NH2 (SL-NH2, a synthetic PAR-2 agonist 
peptide) and LRGILS-NH2 (control peptide with the reverse se-
quence) (Nystedt et al., 1994) were purchased from COSMO 
Genetech (COSMO Genetech Inc., Korea). All other drugs were 
purchased from Sigma-Aldrich. All drugs were dissolved in dis-
tilled water as stock solutions (1-100 mM).  
 
Data analysis 
Data are presented as the means  SEM, with the number of 
experiments denoted within parentheses. The concentration-
response curves of trypsin and SR-NH2 for ICa inhibition were 
calculated by fitting the data to a single-site binding isotherm with 
least-squares nonlinear regression using Prism 5.0 (GraphPad, 
USA). We used unpaired Student’s t-tests to compare data from 
two groups. Differences were considered statistically significant 
at P < 0.05. 
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RESULTS 
 
PAR-2 agonists inhibit ICa in rat CG neurons 
To determine the relationship between PAR-2 and N-type volt-
age-gated Ca2+ channels directly, we examined the effects of 
PAR-2 agonists on ICa using the conventional voltage clamp 
method in dissociated CG neurons. These neurons contribute to 
regulating the peripheral vascular sympathetic tone of the mes-
enteric artery (Whorlow et al., 1996). We first performed 
immunoblotting to confirm the presence of PAR-2 protein in CG 
neurons. Consistent with previous data (Chien et al., 2003), the 
expression of PAR-2 protein, with a predicted weight of 52 kDa, 
was identified in rat lung tissue, but was not detected in rat liver 
tissue. In addition, immunoreactivity of PAR-2 protein was also 
detected, indicating the presence of PAR-2 protein in rat CG 
neurons (Supplementary Fig. S1).  
To measure ICa in rat CG neurons, the current was evoked by 
200 ms depolarizing step pulsesto a test potential of 0 mV from 
a holding potential of -80 mV. The average membrane capaci-
tance of the CG neurons was 30.6  0.3 pF (n = 56). Figure 1A, 
left shows a typical example of the effect of trypsin on the ICa in 
CG neurons. Application of 30 nM trypsin irreversibly diminished 
ICa by 47.5  0.6% (1017.7  134.9 pA for control; 529.3  64.1 pA 
for trypsin, n = 7) (Figs. 1A and 1C). Likewise, 100 M SL-NH2 
(PAR-2 activating peptide) also decreased ICa by 45  1.5% in an 
irreversible manner (1216.1  118.4 pA for control, 688.1  56.1 
pA for SL-NH2, n = 7) (Figs. 1D and 1F). The PAR-2 agonists in-
hibited ICa over the voltage range of -40 mV to +40 mV according 
to the current-voltage (I-V) relationship (Figs. 1A, right and 1D, 
right). BT (boiled trypsin) (30 nM) (Figs. 1B and 1C) did not affect  
Fig. 1. PAR-2 agonists inhibit ICa in 
rat CG neurons. (A) Left, a repre-
sentative trace of ICa in the presence 
(●) and absence (○) of 30 nM tryp-
sin. Midle, time course of the effect 
of 30 nM trypsin on ICa. Right, I–V 
relationship curve of ICa measured 
10 ms after the onset of the depo-
larizing pulses in the absence (○) 
and presence (●) of 30 nM trypsin. 
(B) Left, a representative trace of ICa
in the presence (●) and absence (○) 
of 30 nM BT. Right, time course of 
BT (30 nM)-induced ICa inhibition. 
(C) Summary of ICa inhibition by 
trypsin or BT. (D) Left, representa-
tive traces of ICa in the presence (●) 
and absence (○) of 100 M SL-NH2. 
Middle, time course of 100 μM SL-
NH2 -induced ICa inhibition. Right, I-V 
relationship curve of ICa measured 
10 ms after the onset of the depo-
larizing pulses in the absence (○) 
and presence (●) of 100 M SL-
NH2. (E) Left, representative traces 
of ICa in the presence (●) and ab-
sence (○) of 100 M LR-NH2. Right, 
time course of the 100 μM LR-NH2
effect on ICa. (F) Summary of ICa
inhibition by SL-NH2 or LR-NH2. (G) 
Concentration response curve for 
trypsin- or SL-NH2-induced ICa inhi-
bition. n = 7 in all groups. 
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ICa (inhibition 3.3  1.1%; 1099.8  151.3 pA for control, 1057.1  
132.7 pA for BT, n = 7, P > 0.05). Similarly, 100 M LR-NH2 (in-
active peptide) (Figs. 1E and 1F) did not affect ICa (inhibition 2.3 
 2.2%; 1069.7  110.8 pA for control, 1040.4  103.5 pA for LR-
NH2, n = 7, P > 0.01). We generated concentration–response 
curves for the PAR-2 agonist-induced ICa inhibition. The concen-
tration at which the PAR-2 agonists inhibited ICa in CG neurons 
by 50% was approximately 30 nM for trypsin, and 100 M for 
SL-NH2 (Figs. 1G and 1H). For comparison, thrombin (a PAR-1 
activator; 30 nM) had little effect on ICa in rat CG neurons (6.3  
1% inhibition; control, 1147.7  287.4 pA; thrombin, 1061.1  
235.1 pA, n = 7) (Supplementary Fig. S2). These results suggest 
that voltage-gated Ca2+ channels are modulated primarily by 
PAR-2 activation, rather than by PAR-1 activation. 
 
Intracellular GDPβS prevents ICa inhibition by PAR-2  
agonists 
We determined the involvement of G proteins in PAR-2 agonist-
induced ICa inhibition using GDPβS, a hydrolysis-resistant GDP 
analogue known to prevent G protein activation (Holz et al., 
1986). As shown in Figs. 2A and 2B, intracellular dialysis of 
GDPβS (2 mM) significantly decreased ICa inhibition induced by 
30 nM trypsin (47.3  1.7% for control group, 7.3  1% for 
GDPβS group, n = 7 respectively, P < 0.01). Similarly, SL-NH2 
(100 M) had little effect on ICa in the presence of GDPS (47.6 
 3.5% for control group, 4.9  2.5% for GDPβS group, n = 7 
respectively, P < 0.01) (Figs. 2C and 2D). These results suggest 
that PAR-2 agonists inhibited ICa mainly through activation of 
PAR-2 in rat CG neurons.  
 
Characterization of PAR-2 agonists-induced ICa inhibition 
Next, we investigated the characteristics of PAR-2 agonist-
induced ICa inhibition in rat CG neurons. Consistent with previous 
results (Carrier and Ikeda, 1992), rat CG neurons displayed a 
large ICa, with about 60% attributable to the -CgTx-sensitive N-
type Ca2+ current (ICa-N) (65.1  3.4% for -CgTx; 35.5  3.8% for 
nifedipine, n = 5) (Figs. 3A and 3B). To exclude a possible syn-
ergic effect of -CgTx and nifedipine, we also investigated the 
effect of nifedipine and -CgTx on ICa separately. As shown in 
Supplementary Fig. S5, nifedipine (1 M) decreased ICa by about 
37.1% (785.5  57.1 pA for control; 494.5  49.9 pA for nifedipine, 
n = 5). In addition, -CgTx (1 M) inhibited ICa by 67.3% (703.2  
29.7 pA for control; 227.0  22.5 pA for -CgTx, n = 5). Next, we 
determined whether N-type Ca2+ channels were modulated by 
PAR-2 agonists using a -CgTx prevention experiment. Figure 
3C shows a representative trace of the effects of trypsin (30 nM) 
on ICa in the presence of -CgTx (1 M). Trypsin-induced ICa 
inhibition was almost completely prevented by application of -
CgTx (-0.6  2.5%, n = 7, P < 0.01) (Figs. 3C and 3D). Likewise, 
SL-NH2-induced ICa inhibition was also almost completely pre-
vented by application of -CgTx (-2.1  4.3%, n = 7, P < 0.01) 
(Figs. 3E and 3F). To ensure that PAR-2 agonists inhibit mainly 
ICa-N in CG neurons, we reinvestigated the effect of PAR-2 ago-
nists on ICa in the presence of nifedipine, which blocks L-type 
Ca2+ channels exclusively. These channels represent another 
major Ca2+ channel population in rat CG neurons. As shown in 
Supplementary Figs. S6A and S6C, trypsin inhibited ICa in the 
presence of nifedipine (1 M), similar to trypsin’s effect on ICa-N 
without nifedipine (75.2  3.4%, n = 5). Likewise, SL-NH2 also 
inhibited ICa in the presence of nifedipine (1 M) (70.2  1.3%, n 
= 5) (Supplementary Figs. S6D and S6F). In addition, Supple-
mentary Figs. S6B and S6E, shows a representative trace of the 
effect of -CgTx on inhibition of ICa by PAR-2 agonists in the 
presence of nifedipine. In the presence of nifedipine (1 M), 
trypsin-induced ICa inhibition was still abolished by application of 
-CgTx, similar to the data in Fig. 3 (5.0  1.2%, n = 5, P < 
0.001) (Supplementary Figs. S6B and S6C). Likewise, SL-NH2-
induced ICa inhibition was also almost completely abolished by 
application of -CgTx in the presence of nifedipine (5.4  0.8%, 
n = 5, P < 0.001) (Supplementary Figs. S6E and S6F). Many 
neurotransmitters, such as NA, inhibit ICa-N in a voltage-
dependent manner (Elmslie et al., 1990). Hallmarks of this form 
of voltage-dependent inhibition include kinetic slowing, prepulse 
facilitation, and relief of current inhibition by conditioning 
Fig. 2. Effect of GDPS on PAR-2 ago-
nist-induced ICa inhibition. (A) Left, a rep-
resentative trace showing the effect of 
trypsin (30 nM) on ICa. Open (○) and filled 
circles (●) indicate ICa before and after 
trypsin application, respectively. Right, a 
representative trace showing the effect of 
trypsin (30 nM) on ICa with GDPS (2 
mM) in the pipette solution. Trypsin was 
applied to rat CG neurons after 7 min 
dialysis with GDPS in the pipette solu-
tion. (B) Summary showing the effect of 
GDPS on trypsin-induced ICa inhibition.
(C) Left, a representative trace showing 
the effect of SL-NH2 (100 M) on ICa. 
Open (○) and filled circles (●) indicate ICa
before and after SL-NH2 application,
respectively. Right, a representative trace 
showing the effect of SL-NH2 (100 μM) 
on ICa with GDPS (2 mM) in the pipette 
solution. SL-NH2 was applied to rat CG 
neurons after 7 min dialysis with GDPS 
in the pipette solution. (D) Summary 
showing the effect of GDPS on SL-NH2-
induced ICa inhibition. 
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and SL-NH2 (100 M) on ICa. Trace 1, 2, and 3 in the left panel represent the traces recorded at the corresponding time indicated in the right 
panel, respectively. (F) Summary of ICa inhibition by SL-NH2 in the absence and presence of -CgTx. 
 
 
 
depolarizing pulses. Consistent with previous data (Schofield, 
1991; Shapiro et al., 1994), NA-induced ICa inhibition displayed 
hallmarks of voltage-dependent inhibition, namely kinetic slowing 
and relief of current inhibition by conditioning depolarizing pulses.
Prepulse facilitation, which is defined as the ratio of the 
postpulse to prepulse current amplitude, also increased from 1.1 
 1.7 to 1.7  0.1 (P < 0.05, n = 6) after NA application (Fig. 4A). 
However, PAR-2 agonist-induced ICa inhibition did not show any 
characteristics of voltage-dependent inhibition (Fig. 4B). Moreo-
ver, prepulse facilitation was not significantly affected by 30 nM 
trypsin (control, 1.2  0.09; trypsin, 1.2  0.1, n = 7, P > 0.05) or 
100 M SL-NH2 (control, 1.2  0.04, SL-NH2, 1.3  0.08, P > 
0.05) (Fig. 4C). Taken together, these results suggest that PAR-2 
agonists inhibited -CgTx-sensitive ICa–N in a voltage-
independent manner in rat CG neurons.  
 
Effects of PAR-2 agonists on the repetitive firing of action 
potentials (APs) in CG neurons 
The role of PAR-2 in regulating neuronal excitability was deter-
mined by measuring AP firing frequency in rat CG neurons. APs 
were evoked by constant-current injection through the patch 
pipette in current clamp mode. As shown in Fig. 5, Supplemen-
tary Figs. S3 and S4, injection of positive current (100-300 pA) 
for 300 ms evoked APs in rat CG neurons with a frequency of 
16.8  0.8 Hz (n = 48). Figure 5A shows a typical example of the 
effect of trypsin on the AP firing frequency in rat CG neurons. 
Application of 30 nM trypsin reduced AP firing frequency by 47.5 
 1.6% (17.1  2.8 Hz for control, 11.4  2.2 Hz for trypsin, n = 7, 
P < 0.05). However, BT (30 nM) did not have any effect on the 
frequency (16.2  2.4 Hz for control, 15.2  2.0 Hz for BT, n = 7, 
P > 0.05) (Supplementary Fig. S3A). Likewise, 100 M SL-NH2 
also decreased AP firing frequency by 45.2  2.6% (16.6 Hz  
2.1 Hz for control, 10.2  1.1 Hz for SL-NH2, n = 7, P < 0.05) (Fig. 
5B). However, 100 M LR-NH2 had no influence on frequency 
(15.2  2.0 Hz for control, 14.3  2.3 Hz for LR-NH2, n = 7, P > 
0.05) (Supplementary Fig. S3B). 
To determine whether inhibition of AP firing by PAR-2 agonists is 
mediated by N-type Ca2+ channels, we examined the effect of -
CgTx on AP firing evoked by current injection in rat CG neurons. 
As shown in Figs. 5C and 5D, -CgTx (1 M) significantly sup-
pressed the AP firing rate (18.1  1.2 Hz for control, 8.6  0.7 Hz 
for -CgTx, n = 14, P < 0.001), indicating that membrane excita-
bility may be regulated by N-type Ca2+ channel activity. In addi-
tion, -CgTx (1 M) almost completely abolished the inhibitory 
effect of trypsin (30 nM) on AP firing in rat CG neurons (3.7  
1.9%, n = 7, P > 0.05) (Fig. 5C). Likewise, SL-NH2 (100 M) had 
no influence on AP firing rate in the presence of -CgTx (4.2  
3.0%, n = 7, P > 0.05) (Fig. 5D). For comparison, thrombin (30 
nM) had little effect on AP firing in rat CG neurons (control, 15.6 
 0.7 Hz; thrombin, 15.6  0.7 Hz, P > 0.05, n = 6) (Supplemen-
tary Fig.  S4). These results suggest that PAR-2 activation may 
regulate the membrane excitability of peripheral sympathetic 
neurons through modulation of N-type Ca2+ channels in rat CG 
neurons. 
 
DISCUSSION 
 
The present study demonstrates that PAR-2 activation in rat CG  
Fig. 3. Effect of -CgTx on ICa and PAR-
2 agonist-induced ICa inhibition. (A) Left, 
a representative trace showing the 
effect of consecutive application of -
CgTx (1 M) and nifedipine (1 M) on 
ICa. Right, time course of the effects 
induced by consecutive application of -
CgTx (1 M) and nifedipine (1 M) on 
ICa. Trace 1, 2, and 3 in the left panel
represent the traces recorded at the 
corresponding time indicated in the right 
panel, respectively. (B) Contribution of 
N-type (-CgTx-sensitive) and L-type 
(nifedipine-sensitive) currents to the total 
ICa. (C) Left, a representative trace of the 
effects induced by consecutive applica-
tion of -CgTx (1 M) and trypsin (30
nM) on ICa. Right, time course of effects 
induced by consecutive application of -
CgTx (1 M) and trypsin (30 nM) on ICa.
Trace 1, 2, and 3 in the left panel repre-
sent the traces recorded at the corre-
sponding time indicated in the right 
panel, respectively. (D) Summary of ICa
inhibition by trypsin in the absence and 
presence of -CgTx. (E) Left, a repre-
sentative trace of the effects induced by 
consecutive application of -CgTx (1 
M) and SL-NH2 (100 M) on ICa. Right,
time course of effects induced by con-
secutive application of -CgTx (1 M)
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Fig. 4. Characteristics of PAR-2 agonist-induced ICa inhibition in rat 
CG neurons. (A) Left, a representative trace of ICa inhibition by NA (1 
M) application. Right, time course of prepulse facilitation in the 
absence and presence of 1 M NA. The ICa was evoked every 10 s 
by a double-pulse voltage protocol consisting of two identical test 
pulses (0 mV from a holding potential of -80 mV) separated by a 
large depolarizing conditioning pulse to +80 mV. Prepulse facilitation 
was calculated as the ratio of the postpulse to prepulse current am-
plitudes (post/pre) measured isochronally at 10 ms after the start of 
the test pulse. (B) Left, a representative trace of ICa inhibition by tryp-
sin (30 nM) application. Right, time course of prepulse facilitation in 
the absence and presence of 30 nM trypsin. (A) Left, a representa-
tive trace of ICa inhibition by SL-NH2 (100 M) application. Right, time 
course of prepulse facilitation in the absence and presence of 100 
M SL-NH2. 
 
 
 
neurons inhibits N-type Ca2+ channels, which may play a role in 
suppression of peripheral sympathetic activity.  
Al-Ani et al. (1995) first reported that PAR-2 agonists caused 
an endothelium-dependent relaxation in rat aortic rings, and that 
this vasorelaxing effect was partially prevented by the nitric oxide 
(NO) synthase inhibitor L-NAME. Since then, PAR-2 activation 
has been reported to be involved in vasorelaxation under NO-
dependent and -independent manners in various vascular tis-
sues, such as porcine coronary arteries (Hamilton et al., 1998; 
Hwa et al., 1996), rat femoral arteries (Emilsson et al., 1997; Roy 
et al., 1998), rat renal mesenteric pulmonary arteries (Roy et al., 
1998), and basilar arteries (Sobey and Cocks, 1998; Sobey et 
al., 1999). In addition, it has been shown in vivo that PAR-2 ago-
nist peptides (SL-NH2 or SLIGKV-NH2) applied by intravenous 
injection cause hypotension in anesthetized rats (Cicala et al., 
1999; Emilsson et al., 1997) and mice (Cheung et al., 1998; 
Damiano et al., 1999), and that this PAR-2-induced hypotension 
is also partially inhibited by L-NAME, consistent with in vitro 
results (Cicala et al., 2001; Emilsson et al., 1997). As for NO-
independent vasorelaxation by PAR-2 activation, though several 
mechanisms have been suggested to explain NO-independent 
relaxation by PAR-2 (Hughes et al., 2013; McGuire, 2004; 
McGuire et al., 2002), a detailed mechanism remains to be elu-
cidated.  
The peripheral sympathetic nervous system plays a significant 
role in the regulation of blood flow by modulating peripheral vas-
cular resistance. The postganglionic fibers from peripheral sym-
pathetic ganglionic neurons, which innervate resistance arterial 
beds, are involved in the regulation of peripheral vascular tone 
through NA release from sympathetic nerve terminals. In addi-
tion, voltage-dependent N-type Ca2+ channels, which are located 
at peripheral sympathetic nerve terminals, play a pivotal role in 
modulating peripheral sympathetic activity in postganglionic 
sympathetic neurons (Molderings et al., 2000; Shimosawa et al., 
2004). Increases in intracellular Ca2+ concentration, caused by 
Ca2+ influx through N-type voltage-gated Ca2+ channels, trigger 
NA release in peripheral sympathetic nerve terminals. Thus, if 
PAR-2 activation inhibits NA release by regulating N-type Ca2+ 
channel activity in peripheral sympathetic nerve terminals, this 
can cause suppression of peripheral sympathetic tone, which in 
turn reduces blood pressure. In fact, our group recently ob-
served that PAR-2 agonists suppress neurogenic contraction 
and overflow of NA release evoked by electrical field stimulation, 
which mimics vasoconstriction, and that this suppression was 
almost completely prevented by w-CgTx, a potent N-type Ca2+ 
channel blocker (unpublished data). These results strongly sug-
gest that activation of PAR-2 may suppress peripheral sympa-
thetic outflow by modulating N-type Ca2+ channel activity in pe-
ripheral sympathetic nerve terminals, which appear to be in-
volved in PAR-2-induced hypotension. Therefore, we sought 
direct evidence for a relationship between N-type Ca2+ channels 
and PAR-2 in peripheral sympathetic neurons. In the present 
study, PAR-2 agonists irreversibly diminished ICa in rat CG neu-
rons, while thrombin had little effect on ICa. In addition, blockage 
of N-type Ca2+ channels with -CgTx almost completely pre-
vented ICa inhibition by PAR-2 agonists. Furthermore, PAR-2 
agonists reduced the membrane excitability of CG neurons in an 
irreversible manner, and the blockage of N-type Ca2+ channels 
with -CgTx almost completely prevented inhibition of AP firing 
by PAR-2 agonists. These results, therefore, suggest that the 
suppression of peripheral sympathetic activity by PAR-2 agonists 
is mediated mainly by the inhibition of N-type Ca2+ channels 
located in peripheral sympathetic nerve terminals. 
In sympathetic ganglia neurons, Ca2+ influx through N-type Ca2+ 
channels is needed to maintain repetitive AP firing. In fact, -
CgTx, GVIA, or Ca2+-free buffers significantly suppress the re-
petitive APs evoked by current injection in bronchial ganglion 
neurons (Myers, 1998). Thus, inhibition of ICa-N by neurotransmit-
ters may attenuate the excitability of the peripheral sympathetic 
nervous system. In the present study, PAR-2 agonists reduced 
the membrane excitability of CG neurons in an irre versible 
manner (Figs. 7A and 7B). Consistent with previous reports, -
CgTx significantly reduced firing frequency of APs evoked by 
current injection in rat CG neurons. Blocking N-type Ca2+ chan-
nels with -CgTx almost completely abolished the inhibition of 
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AP firing by PAR-2 agonists (Figs. 7C and 7D). This result sug-
gests that ICa-N inhibition by PAR-2 activation may reduce the 
excitability of peripheral sympathetic ganglion neurons and the 
relay of excitatory stimuli to sympathetic nerve terminals. In addi-
tion, if N-type Ca2+ channels are functionally coupled to PAR-2 at 
sympathetic nerve terminals in rat CG neurons, as they are in 
the soma, the activation of PAR-2 may suppress the release of 
NA by decreasing the intracellular Ca2+ concentration through 
inhibition N-type Ca2+ channels directly, as in Dunlap & 
Fischbach’s general concept of presynaptic inhibition 
(Shimosawa et al., 2004). As for the irreversible nature of the 
suppression of ICa-N by PAR-2 activation, we cannot suggest a 
feasible explanation based on the results obtained from this 
study. PAR-2 activated by irreversible proteolysis that results in 
continuous stimulation; however, cleaved PAR-2 is known to be 
rapidly ubiquitinated at the C-terminus, which mediates down-
regulation of PAR-2 to terminate signaling. A more detailed study 
is needed to clearly explain this phenomenon. 
In conclusion, the present findings demonstrate that the acti-
vation of PAR-2 suppresses peripheral sympathetic outflow by 
modulating N-type Ca2+ channel activity in peripheral sympathet-
ic nerve terminals, which appear to be involved in PAR-2-
induced hypotension. In addition, PAR-2 activation inhibits N-
type Ca2+ channel activity in a voltage-independent manner, and 
this inhibition attenuates repetitive AP firing in CG neurons. The-
se results provide a detailed neuronal mechanism for PAR-2-
induced hypotension and a basic and theoretical framework that 
could lead to the development of new agents for the treatment of 
hypertension. 
 
Note: Supplementary information is available on the Molecules 
and Cells website (www.molcells.org). 
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